Protecting minds
Lead the shift from late diagnosis to early prevention.
Dementia research is reaching a pivotal moment. Leadership-level support enables ·¬ÇÑÊÓÆµ to act decisively - when timing matters most.
Why this moment matters
For decades, dementia treatments delivered limited progress. Promising discoveries stalled before reaching patients.
That landscape is changing.
- At-home blood biomarker testing is showing potential to detect Alzheimer’s risk earlier and more efficiently.
- The PROTECT platform now engages more than 50,000 participants worldwide.
- The REACTIVE programme is developing new pathways for earlier triage and diagnosis.
This is not incremental research. It is a structural shift in how dementia is understood and addressed.
At this stage, progress is shaped by timing, infrastructure and confidence.

What your leadership enables
Leadership-level support (from £1,000 per year / £84 per month) allows ·¬ÇÑÊÓÆµ to:
- Launch ambitious trials outside traditional funding cycles
- Scale disruptive technologies
- Accelerate repositioned drug studies
- Invest early in high-potential ideas
Are you ready to lead?
Contact: Vic Owens, Leadership Development Officer
Email: v.owens@exeter.ac.uk
Phone: 01392 723141